Chuck Tuchinda is the executive vice president and deputy group head of Hearst Health, providing senior leadership for Hearst’s healthcare businesses in the U.S. and globally, including FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MedHOK, Hearst Health Ventures and the Hearst Health Innovation Lab. He also serves as president of FDB and is an advisor to M2Gen.
The mission of Hearst Health is to guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 70 million home health visits and 3.2 billion dispensed prescriptions.
From the outset of his career, Tuchinda has invented and commercialized solutions that leverage modern technology to improve clinical decision making. His expertise is in developing scalable and sustainable business models for novel technology-enabled clinical knowledge.
Tuchinda became president of FDB in 2014, leading the company in double-digit growth and expanding its business into adjacent markets. He first joined Hearst in 2010 as the chief innovation officer for healthcare, after holding a variety of executive roles at Eclypsis (now Allscripts) and leading several successful entrepreneurial endeavors.
A board certified internal medicine physician, Tuchinda completed both his medical doctorate and residency training at Johns Hopkins. He received a master’s degree in business administration from Harvard Business School and a biomedical engineering degree from Harvard College.